Table 2.

Linear regression of PASP, entire cohort.

Variables	β-estimate (mmHg) [95% CI]*	p value
HIV/HCV status
Uninfected	Ref	–
HIV mono-infected	0.002 [− 0.93, 0.93]	0.9963
HCV mono-infected	0.45 [− 0.66, 1.57]	0.4259
Co-infected	1.10 [0.01, 2.20]	0.0484
Age, 10 years	0.21 [− 0.22, 0.63]	0.3453
Race
White	Ref	–
African American	2.02 [ 1.20, 2.85]	< .0001
Hispanic	− 3.31 [− 4.56, − 2.06]	< .0001
Other	0.16 [− 2.17, 2.49]	0.8953
Male Sex	7.40 [5.31, 9.50]	< .0001
BMI	0.04 [− 0.02, 0.10]	0.2436
Heart failure status
HF Preserved EF	7.83 [6.18, 9.48]	< .0001
HF with EF between 40 & 50	6.46 [4.00, 8.92]	< .0001
HF Reduced EF	5.78 [4.37, 7.18]	< .0001
No EF	7.94 [6.90, 8.98]	< .0001
No HF	Ref	–
History of CHD	1.02 [0.24, 1.80]	0.0102
Hypertension
No Hypertension	Ref	–
Controlled HTN	0.31 [− 1.27, 1.88]	0.7003
Uncontrolled HTN	1.65 [− 0.02, 3.31]	0.0523
COPD	1.96 [1.19, 2.72]	< .0001
Stroke History	− 1.19 [− 2.55, 0.16]	0.0844
Diabetes Mellitus	0.89 [0.13, 1.66]	0.0214
Dyslipidemia	− 0.44 [− 1.18, 0.30]	0.2480
Smoking status
Current	0.46 [− 0.50, 1.43]	0.3438
Former	0.91 [− 0.19, 2.02]	0.1049
Never	Ref	–
Alcohol Use	0.21 [− 0.67, 1.09]	0.6346
Cocaine Use	− 1.53 [− 2.55, − 0.50]	0.0034
eGFR	− 0.03 [− 0.04, − 0.01]	< .0001
FIB-4	0.31 [0.17, 0.45]	< .0001
Hemoglobin	− 0.75 [− 0.94, − 0.56]	< .0001

PASP pulmonary arter systolic pressure, HCV hepatitis C virus, CI confidence interval, BMI body mass index, HF heart failure, EF ejection fraction, CHD coronary heart disease, HTN hypertension, COPD chronic obstructive pulmonary disease, eGFR estimated glomerular filtration rate; FIB-4 fibrosis 4 score.

*All estimates are from a multiple linear regression adjusted for all listed variables. Estimates per one unit increase unless otherwise specified.